Lipid-Peptide Conjugation

High-Quality Lipid-Peptide Conjugates from BOC Sciences

BOC Sciences has extensive experience in lipid-peptide conjugation and supports the custom coupling of a wide variety of lipid and peptide molecules. Whether fatty acids, cholesterol, phospholipids, or functional synthetic lipids, we can select appropriate lipid structures and optimize conjugation strategies based on client requirements. Additionally, we handle various functional peptides—including antimicrobial, cell-penetrating, targeting, and signal peptides—to ensure that conjugates achieve optimal membrane permeability, in vivo stability, and targeting performance. With this comprehensive capability, BOC Sciences provides high-quality, customized lipid-peptide conjugation solutions for applications in drug delivery, vaccine development, antimicrobial research, and nanomaterial design.

Fatty Acid-Peptide Conjugates

• Formed by linking fatty acids such as palmitic acid, stearic acid, or lauric acid to peptides through amide or ester bonds.
• These conjugates enhance peptide hydrophobicity and membrane affinity, improving in vivo stability and plasma half-life.
• Widely used in research aimed at extending peptide drug half-life and enhancing pharmacological efficacy.

Cholesterol-Peptide Conjugates

• Coupling cholesterol molecules with peptides improves membrane-binding capacity and circulation stability.
• Enhances peptide delivery efficiency, especially in nucleic acid and drug carrier systems.
• Commonly applied in tumor-targeted therapy, siRNA/antibody delivery, and vaccine development.

Phospholipid-Peptide Conjugates

• Conjugates formed using phospholipid molecules such as phosphatidylcholine or phosphatidylethanolamine.
• They can self-assemble into liposomes or nanoparticles for drug carrier and antigen delivery applications.
• Suitable for vaccine development, nano-delivery systems, and membrane-related studies.

Synthetic Lipid-Peptide Conjugates

• Utilize structurally tunable synthetic lipids for conjugation, enabling functional and responsive design.
• Can be tailored for acid-sensitive, enzyme-sensitive, or redox-responsive behavior for controlled and targeted release.
• Ideal for targeted delivery, nanomaterial development, and advanced drug design.

Functional Peptide-Lipid Conjugates

• Include antimicrobial, cell-penetrating, targeting, and signal peptides conjugated with lipids.
• Lipid modification enhances membrane penetration and in vivo stability while maintaining peptide-specific biological functions.
• Broadly applied in antimicrobial therapy, drug delivery, targeted therapy, and cellular research.

Tailored Lipid-Peptide Conjugation Solutions for Biotech and Pharma

BOC Sciences possesses extensive R&D experience in lipid-peptide conjugation, integrating advanced chemical synthesis platforms and nanotechnology to provide high-quality, customized lipid-peptide conjugation solutions for research institutions, pharmaceutical companies, and biotechnology firms. Our professional team has deep expertise in lipid compound design and peptide conjugation strategies and can deliver optimized solutions tailored to different application scenarios such as peptide drug delivery, vaccine development, and nanocarrier design. Through strict quality control and flexible production scales, BOC Sciences transforms complex lipid-peptide conjugation projects into high-performance, reproducible products, offering comprehensive support for clients' research and product development.

Lipid-Peptide Molecular Design

• Design lipid chain length, saturation, and linkage mode according to client needs to optimize solubility, stability, and delivery efficiency.
• Provide recommendations for selecting targeting or functional peptides to achieve precise targeting and enhanced biological functionality.
• Capable of designing stimulus-responsive (acid-, enzyme-, or redox-sensitive) lipid-peptide conjugates for controlled drug release.

Efficient Chemical Conjugation and Process Optimization

• Employ multiple conjugation strategies such as amide, thioether, click chemistry, and non-covalent complexes to achieve high-efficiency and high-stability conjugation.
• Optimize reaction conditions to balance yield, molecular uniformity, and lipid hydrophobicity, ensuring product control and reproducibility.
• Flexible choice of solid-phase peptide synthesis or solution-phase chemistry to accommodate various peptide sequences and lipid types.

Self-Assembly and Nanostructure Optimization

• Based on molecular characteristics, lipid-peptide conjugates can self-assemble into nanoparticles, micelles, or liposomes to enhance drug loading capacity.
• Precisely control particle size, surface charge, and stability to optimize delivery and targeting efficiency.
• Support functionalized design for drug, nucleic acid, or vaccine carriers, balancing in vivo stability and controlled release performance.

Comprehensive Analysis and Scalable Production

• Provide multidimensional analytical validation using HPLC, LC-MS, and NMR to confirm conjugation efficiency, purity, and structural accuracy.
• Scale from laboratory milligram synthesis to gram or pre-industrial production to meet both R&D and commercial needs.
• GMP-certified facilities ensure high-quality manufacturing and global logistics support, enabling clients to efficiently obtain their products.

Top Benefits of Our Lipid-Peptide Conjugation Services

• Professional Team and Extensive Expertise: Our R&D team comprises experts in chemistry, biology, and nanomaterials, skilled in complex lipid-peptide conjugate design, synthesis optimization, and functional validation to ensure every project meets the highest scientific standards from concept to completion.
• End-to-End Customization: BOC Sciences provides one-stop customized services covering molecular design, chemical conjugation, structural characterization, functional validation, and scalable production to meet clients' diverse R&D requirements.
• High Quality and Rigorous Control: Using multidimensional analytical technologies such as HPLC, LC-MS, and NMR, we rigorously assess conjugation efficiency, molecular purity, and structural integrity to guarantee product quality and reproducibility.
• GMP-Certified Facilities: Our manufacturing facilities comply with GMP standards, ensuring safety, consistency, and quality control throughout the lipid-peptide conjugate production process, providing clients with reliable assurance.
• Flexible Scale and Global Delivery: From milligram-scale laboratory preparation to gram or pilot-scale production, BOC Sciences offers flexible manufacturing and global logistics support for fast and reliable delivery to research and commercial clients.
• Extensive Application Experience: With rich experience in peptide drug delivery, vaccine development, antimicrobial and antiviral therapy, nanomaterial design, and biological research, we provide mature technical support and optimized solutions for a broad range of applications.
• Customer Support and Technical Consultation: BOC Sciences offers professional technical consulting and project support to help clients optimize conjugation strategies, select suitable lipid and peptide combinations, and resolve technical challenges encountered during development.

Lipid-Peptide Conjugation Service Workflow: From Design to Delivery

The lipid-peptide conjugation service workflow at BOC Sciences is scientifically and systematically designed, covering the full cycle from project consultation to final product delivery. This ensures efficient, controllable, and high-quality output. Beyond chemical conjugation, we integrate the functional characteristics of lipids and peptides to deliver tailored solutions that support both research and industrial-scale applications.

Client Consultation

• We begin by understanding the project objectives, peptide sequences, lipid preferences, and intended applications.
• Our experts provide professional design recommendations, determine the optimal conjugation strategy, and assess technical feasibility and development timelines.

Molecular Design and Project Evaluation

• We design the molecular architecture of lipid-peptide conjugates, including linkage chemistry, lipid types, and stimulus-responsive configurations.
• Feasibility, stability, and solubility are evaluated to develop an optimized plan. Simulation modeling and risk assessment are also performed to guide decision-making.

Chemical Synthesis and Conjugation

• We employ solid-phase peptide synthesis (SPPS), solution-phase chemical coupling, or enzyme-mediated conjugation to achieve efficient linkage.
• Reaction conditions are fine-tuned to maximize yield and uniformity while minimizing by-products and improving purity.

Purification and Characterization

• Purification and structural verification are performed using HPLC, LC-MS, and NMR.
• We assess conjugation efficiency, self-assembly behavior, and particle size distribution, along with stability and batch consistency analyses to ensure reproducibility.

Functional Validation and Performance Optimization

• Depending on the intended application, preliminary in vitro or in vivo testing is conducted to evaluate membrane permeability, stability, and targeting.
• Feedback-driven optimization is performed by adjusting lipid chain length, conjugation sites, or self-assembly parameters to achieve ideal performance.

Scale-Up and Delivery

• We offer gram-scale and pre-industrial-scale production under strict GMP-compliant quality control.
• Customized packaging and global logistics support ensure rapid delivery of high-quality products, with ongoing technical assistance for downstream applications.

Exploring Lipid-Peptide Conjugate Applications in Drug Discovery

BOC Sciences' lipid-peptide conjugation services are applicable across diverse fields, including drug delivery, vaccine development, antimicrobial and antiviral therapy, nanotechnology, and fundamental biomedical research. Through lipid modification, peptides gain enhanced in vivo stability, membrane permeability, and targeting ability—empowering researchers and developers to design more efficient molecular delivery systems.

Peptide Drug Delivery

• Lipid-peptide conjugation greatly improves the stability and plasma half-life of peptide drugs, reducing enzymatic degradation while enhancing membrane permeability for better cellular uptake.
• Examples include GLP-1 analogs for diabetes treatment and various anticancer peptides, which benefit from improved pharmacokinetic and therapeutic profiles.
• Additionally, lipid-modified peptides can self-assemble into nanostructures for controlled drug release, prolonged circulation, and increased bioavailability.

Vaccine Development and Immunoadjuvant Design

• By conjugating antigenic peptides with lipids to form nanoparticles, immunogenicity and antibody production are significantly enhanced.
• Lipid-peptide conjugates can target dendritic cells or lymphatic tissues, promoting T-cell activation and immune memory formation.
• They are applied in peptide-based vaccine design and mRNA delivery systems for infectious disease and cancer immunotherapy.

Antimicrobial and Antiviral Applications

• Lipid-antimicrobial peptide conjugates enhance membrane penetration and antimicrobial potency while reducing cytotoxicity.
• These conjugates are used for infection control, antiviral therapy, and surface modification of biomedical devices and materials.
• Optimized lipid-peptide combinations yield broad-spectrum antimicrobial effects with improved therapeutic safety.

Nanodelivery Systems

• Lipid-peptide conjugates can self-assemble into micelles, liposomes, or nanoparticles for delivering small molecules, nucleic acids, or proteins.
• By controlling particle size, surface charge, and hydrophobic-hydrophilic balance, in vivo stability, circulation time, and targeting efficiency can be optimized.
• Such nanocarriers are widely used in drug delivery, gene therapy, and targeted oncology treatments.

Biological Research Tools

• Lipid-peptide conjugates serve as membrane-active probes to study peptide–membrane interactions, membrane protein functions, and signal transduction pathways.
• They enable simulation of cellular membrane environments to evaluate peptide permeability and binding behaviors.
• These conjugates are valuable tools in drug screening, membrane protein analysis, and cell signaling research.

Targeted Therapy and Cell-Specific Delivery

• Through the use of specific targeting peptides, lipid-peptide conjugates enable selective delivery to particular cells or tissues.
• This strategy enhances therapeutic efficacy while minimizing off-target toxicity, suitable for cancer, inflammation, and immunotherapy research.
• By optimizing lipid structures and conjugation sites, circulation longevity and tissue penetration can be further improved.

Frequently Asked Questions

Still have questions?

Contact Us

• What are peptide-lipid conjugates?

  Peptide-lipid conjugates are hybrid molecules formed by covalently linking peptides with lipid chains. This modification enhances peptide stability, membrane affinity, and bioavailability, making them ideal for drug delivery and vaccine development. Peptide-lipid conjugates can self-assemble into micelles or liposomes, improving cellular uptake and controlled release. They are widely studied in biotechnology, nanomedicine, and antimicrobial research for their ability to combine the biological specificity of peptides with the hydrophobic properties of lipids.

• What are fatty acid-peptide conjugates?

  Fatty acid-peptide conjugates are amphiphilic molecules created by attaching fatty acid chains, such as palmitic or stearic acid, to peptides through covalent bonding. This conjugation increases peptide hydrophobicity, enhances membrane permeability, and prolongs circulation time in biological systems. Fatty acid-peptide conjugates are commonly used to improve drug stability, control release rates, and optimize pharmacokinetics in peptide-based therapeutics. They also serve as model systems for studying lipid-protein interactions and self-assembly in nanostructures.

• Which fatty acids can be used for peptide conjugation?

  Both saturated and unsaturated fatty acids can be used for peptide conjugation. Common examples include palmitic acid (C16:0), stearic acid (C18:0), and lauric acid (C12:0) as saturated types, and oleic acid (C18:1) and linoleic acid (C18:2) as unsaturated types. These fatty acids form amide or ester bonds with peptide chains, enhancing hydrophobicity, membrane affinity, and molecular stability. The length and degree of unsaturation of fatty acid chains influence self-assembly behavior and delivery efficiency.

• Which cholesterols can be used for peptide conjugation?

  Cholesterol and its derivatives-such as cholesteryl hemisuccinate, cholesteryl carboxylic acid, and cholesteryl ethoxycarbonyl compounds—are commonly used for peptide conjugation. These molecules contain reactive functional groups that can form covalent bonds with peptide amine or carboxyl groups. Cholesterol modification improves peptide anchoring within lipid membranes, enhancing cellular uptake, transmembrane transport, and targeted delivery, making it valuable in drug and gene carrier design.

• How does you ensure the quality of lipid-peptide conjugates?

  BOC Sciences adheres to international quality management systems. Each batch of products is validated through multi-dimensional analytical techniques, including HPLC, LC-MS, and NMR, for purity and structural accuracy. All experimental and production processes are conducted in GMP-compliant facilities to guarantee high purity, stability, and batch-to-batch consistency, ensuring reliable support for both research and industrial applications.

• Can lipid-peptide conjugates be customized?

  Yes. BOC Sciences offers fully customized, end-to-end services—covering lipid type, peptide sequence design, conjugation chemistry, and linkage site optimization. Our expert team provides tailored recommendations based on desired functionality (delivery, targeting, or immune activation) to ensure optimal physicochemical and biological properties of the final conjugates.

• Do you support different production scales?

  Yes. BOC Sciences provides flexible production capabilities ranging from milligram-scale laboratory preparation to gram-scale or pre-industrial manufacturing. We support research, preclinical development, and commercial-scale projects with rigorous quality control and traceable data management to ensure consistent performance during scale-up.

• Can lipid-peptide conjugates form nanostructures?

  Yes. Lipid-peptide conjugates exhibit self-assembly properties, forming micelles, liposomes, or nanoparticles. BOC Sciences can optimize lipid chain length, headgroup polarity, and peptide sequence to control particle size and surface properties, ensuring excellent biocompatibility and targeting capability for drug delivery, gene transfection, and vaccine development.

• Are lipid-peptide conjugates suitable for targeted delivery?

  Yes. BOC Sciences designs lipid-peptide conjugates incorporating targeting peptides, cell-penetrating sequences, or recognition motifs for tissue- or cell-specific delivery. Through precise molecular engineering and lipid optimization, these conjugates enhance target accumulation, improve drug utilization, and minimize systemic toxicity, supporting advanced targeted therapy and efficient delivery system development.

Case Studies and Success Stories

Publications

Our publications section features scientific achievements published by our clients in international journals, showcasing research conducted using BOC Sciences' lipid products and custom services.

• Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice. PloS one 12.12 (2017): e0189523. PMID: 29240800 DOI: 10.1371/journal.pone.0189523.
• Baricitinib Liposomes as a New Approach for the Treatment of Sjögren's Syndrome. Pharmaceutics. 2022; 14(9): 1895. DOI: 10.3390/pharmaceutics14091895.
• The long-chain monounsaturated cetoleic acid improves the efficiency of the n-3 fatty acid metabolic pathway in Atlantic salmon and human HepG2 cells. Br J Nutr. 2019; 122(7): 755-768. DOI: 10.1017/S0007114519001478.
• Osteogenic effects of rapamycin on bone marrow mesenchymal stem cells via inducing autophagy. Journal of Orthopaedic Surgery and Research 18.1 (2023): 129. PMID: 36814286 DOI: 10.1186/s13018-023-03616-9.
• Cuban Policosanol (Raydel®) Exerts Higher Antioxidant and Anti-Glycation Activities than Chinese Policosanol (BOC Sciences) in Reconstituted High-Density Lipoproteins: In Vivo Anti-Inflammatory Activities in Zebrafish and Its Embryos. Pharmaceuticals 17.4 (2024): 406. DOI: 10.3390/ph17040406.

Client Testimonials

Industry Distribution of Custom Lipid Synthesis Clients

"We worked with BOC Sciences to synthesize lipid–peptide conjugates for vaccine formulation studies. Their team demonstrated outstanding expertise in peptide modification and lipid chemistry, delivering high-purity products on schedule."

— Dr. Benjamin Harris, Immunology Research Scientist (United States)

"BOC Sciences provided exceptional support for our lipid–peptide conjugation project aimed at improving peptide drug stability. The conjugates showed enhanced membrane permeability and bioavailability in preclinical tests."

— Dr. Katharina Vogel, Biopharmaceutical Scientist (Germany)

"Our collaboration with BOC Sciences focused on developing lipid–peptide conjugates for targeted delivery applications. The synthesis was highly efficient, and their detailed analytical data helped us validate structural integrity."

— Dr. Thomas Blake, Senior Scientist (United Kingdom)

"We commissioned BOC Sciences to design a lipid–peptide conjugate for antimicrobial studies. Their chemists proposed an optimal linker strategy, resulting in improved conjugation yield and superior biological performance."

— Dr. Sofia Bernard, Peptide Chemist (France)

"BOC Sciences delivered lipid–peptide conjugates for our cell-penetrating peptide program. The quality and reproducibility were excellent, and their communication throughout the project was professional and transparent."

— Ms. Julia Novak, Molecular Biology Specialist (Austria)

"BOC Sciences' lipid–peptide conjugation service significantly advanced our formulation research. The products met all analytical specifications and were supported by complete documentation for regulatory submission."

— Dr. Lucas Meyer, Pharmaceutical Development Manager (Switzerland)